174 related articles for article (PubMed ID: 35715663)
1. The presence of symptoms within 6 months after COVID-19: a single-center longitudinal study.
Emecen AN; Keskin S; Turunc O; Suner AF; Siyve N; Basoglu Sensoy E; Dinc F; Kilinc O; Avkan Oguz V; Bayrak S; Unal B
Ir J Med Sci; 2023 Apr; 192(2):741-750. PubMed ID: 35715663
[TBL] [Abstract][Full Text] [Related]
2. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis.
Alkodaymi MS; Omrani OA; Fawzy NA; Shaar BA; Almamlouk R; Riaz M; Obeidat M; Obeidat Y; Gerberi D; Taha RM; Kashour Z; Kashour T; Berbari EF; Alkattan K; Tleyjeh IM
Clin Microbiol Infect; 2022 May; 28(5):657-666. PubMed ID: 35124265
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
Nasserie T; Hittle M; Goodman SN
JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
[TBL] [Abstract][Full Text] [Related]
5. Burden of post-COVID-19 syndrome and implications for healthcare service planning: A population-based cohort study.
Menges D; Ballouz T; Anagnostopoulos A; Aschmann HE; Domenghino A; Fehr JS; Puhan MA
PLoS One; 2021; 16(7):e0254523. PubMed ID: 34252157
[TBL] [Abstract][Full Text] [Related]
6. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
[TBL] [Abstract][Full Text] [Related]
7. Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.
Richard SA; Pollett SD; Fries AC; Berjohn CM; Maves RC; Lalani T; Smith AG; Mody RM; Ganesan A; Colombo RE; Lindholm DA; Morris MJ; Huprikar N; Colombo CJ; Madar C; Jones M; Larson DT; Bazan SE; Mende K; Saunders D; Livezey J; Lanteri CA; Scher AI; Byrne C; Rusiecki J; Ewers E; Epsi NJ; Rozman JS; English C; Simons MP; Tribble DR; Agan BK; Burgess TH;
JAMA Netw Open; 2023 Jan; 6(1):e2251360. PubMed ID: 36652247
[TBL] [Abstract][Full Text] [Related]
8. Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China.
Yang X; Hou C; Shen Y; Zhang M; Zhang K; Wang F; Liu Y; Ma X; Cheng L; Kang J; Hu B; Wang M; Zeng L; Wang Y; He Y; Cao G; Jiang J; Jones P; Cao B; Li L
JAMA Netw Open; 2022 Sep; 5(9):e2231790. PubMed ID: 36107425
[TBL] [Abstract][Full Text] [Related]
9. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study.
Ballouz T; Menges D; Anagnostopoulos A; Domenghino A; Aschmann HE; Frei A; Fehr JS; Puhan MA
BMJ; 2023 May; 381():e074425. PubMed ID: 37257891
[TBL] [Abstract][Full Text] [Related]
10. Serological Biomarkers at Hospital Admission Are Not Related to Long-Term Post-COVID Fatigue and Dyspnea in COVID-19 Survivors.
Fernández-de-Las-Peñas C; Ryan-Murua P; Rodríguez-Jiménez J; Palacios-Ceña M; Arendt-Nielsen L; Torres-Macho J
Respiration; 2022; 101(7):658-665. PubMed ID: 35381597
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study.
Fumagalli C; Zocchi C; Tassetti L; Silverii MV; Amato C; Livi L; Giovannoni L; Verrillo F; Bartoloni A; Marcucci R; Lavorini F; Fumagalli S; Ungar A; Olivotto I; Rasero L; Fattirolli F; Marchionni N;
Eur J Intern Med; 2022 Mar; 97():36-41. PubMed ID: 34903448
[TBL] [Abstract][Full Text] [Related]
12. Fatigue and Dyspnoea as Main Persistent Post-COVID-19 Symptoms in Previously Hospitalized Patients: Related Functional Limitations and Disability.
Fernández-de-Las-Peñas C; Palacios-Ceña D; Gómez-Mayordomo V; Palacios-Ceña M; Rodríguez-Jiménez J; de-la-Llave-Rincón AI; Velasco-Arribas M; Fuensalida-Novo S; Ambite-Quesada S; Guijarro C; Cuadrado ML; Florencio LL; Arias-Navalón JA; Ortega-Santiago R; Elvira-Martínez CM; Molina-Trigueros LJ; Torres-Macho J; Sebastián-Viana T; Canto-Diez MG; Cigarán-Méndez M; Hernández-Barrera V; Arendt-Nielsen L
Respiration; 2022; 101(2):132-141. PubMed ID: 34569550
[TBL] [Abstract][Full Text] [Related]
13. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study.
Xiong Q; Xu M; Li J; Liu Y; Zhang J; Xu Y; Dong W
Clin Microbiol Infect; 2021 Jan; 27(1):89-95. PubMed ID: 32979574
[TBL] [Abstract][Full Text] [Related]
14. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
Huang L; Li X; Gu X; Zhang H; Ren L; Guo L; Liu M; Wang Y; Cui D; Wang Y; Zhang X; Shang L; Zhong J; Wang X; Wang J; Cao B
Lancet Respir Med; 2022 Sep; 10(9):863-876. PubMed ID: 35568052
[TBL] [Abstract][Full Text] [Related]
15. Long-COVID in patients with a history of mild or asymptomatic SARS-CoV-2 infection: a Nationwide Cohort Study.
Adler L; Gazit S; Pinto Y; Perez G; Mizrahi Reuveni M; Yehoshua I; Hoffman R; Azuri J; Patalon T
Scand J Prim Health Care; 2022 Sep; 40(3):342-349. PubMed ID: 36314555
[TBL] [Abstract][Full Text] [Related]
16. Emotional, mental health and physical symptom experience of patients hospitalized with COVID-19 up to 3 months post-hospitalization: A longitudinal study.
Tracy MF; Hagstrom S; Mathiason M; Wente S; Lindquist R
J Clin Nurs; 2024 Feb; 33(2):591-605. PubMed ID: 37698148
[TBL] [Abstract][Full Text] [Related]
17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
18. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
19. Post-Discharge Symptoms among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study.
Ogoina D; James HI; Ogoinja SZ
Am J Trop Med Hyg; 2021 Jul; 105(3):731-736. PubMed ID: 34270448
[TBL] [Abstract][Full Text] [Related]
20. Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study.
Fjelltveit EB; Blomberg B; Kuwelker K; Zhou F; Onyango TB; Brokstad KA; Elyanow R; Kaplan IM; Tøndel C; Mohn KGI; Özgümüş T; Cox RJ; Langeland N;
Clin Infect Dis; 2023 Feb; 76(3):e60-e70. PubMed ID: 35959897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
